Scientists from NTU Singapore, Brown University and Massachusetts Institute of Technology (MIT) have developed an artificialintelligence platform that could one day be used in a system to assess blood vessel anomalies and eyedisease. The AI-powered platform combines machine learning and a specially-designed microfluidic chip. When tested, it accurately predicted blood flow characteristics that may help clinicians in detecting and tracking the progression of vasculardiseases.
